Standard Radiation Treatment

RADIATION3 trials

Sponsors

University of Michigan Rogel Cancer Center, AHS Cancer Control Alberta, NYU Langone Health

Conditions

Breast CancerHPV Positive Oropharyngeal Squamous Cell CarcinomaHigh-risk Prostate CancerOropharyngeal Carcinoma

Phase 1

Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer

CompletedNCT01477489

University of Michigan Rogel Cancer CenterBreast Cancer

Start: 2012-01-31End: 2017-10-31Updated: 2017-12-15

Phase 2

Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma

RecruitingNCT03215719

NYU Langone HealthHPV Positive Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Carcinoma

Start: 2017-10-18End: 2028-12-31Target: 120Updated: 2026-01-06

Unknown Phase

Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients

TerminatedNCT01488968

AHS Cancer Control AlbertaHigh-risk Prostate Cancer

Start: 2012-03-31End: 2018-10-15Updated: 2025-06-29